Categorynews

Global Pigmentation Disorders Treatment Market (2021 to 2026) – Growth, Trends, COVID-19 Impact and Forecasts – ResearchAndMarkets.com

July 2, 2021 Off By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Pigmentation Disorders Treatment Market – Growth, Trends, COVID-19 Impact, and Forecasts (2021 – 2026)” report has been added to ResearchAndMarkets.com’s offering.

The global Pigmentation Disorders Treatment Market was valued at USD 5,591.98 million in 2020, and it is expected to reach USD 8,593.68 million by 2026, registering a CAGR of 7.14% during the forecast period.

Companies Mentioned

  • AbbVie Inc (Allergan, Inc)
  • Episciences, Inc.
  • DermaMed Solutions, LLC
  • L’Oreal S.A.
  • Pierre Fabre Group (Pierre Fabre Laboratories)
  • Vital Esthetique
  • Obagi Cosmeceuticals LLC
  • Pfizer Inc.
  • Galderma S.A.
  • Merz GmbH & Co. KGaA

Key Market Trends

Topical Treatment Segment is Expected to Hold Significant Market Share Over the Forecast Period

Currently, topical treatment segment is dominating the global market due to the improved clinical outcomes in patients suffering from pigmentation disorders. The most common topical drugs prescribed globally are azelaic acid, hydroquinone, L-ascorbic acid, etc. Topical treatment includes topical application of creams, lotions, ointments, and serums that are formulated using various active ingredients to treat different pigmentation conditions.

As per the National Clinical Trials (NCT) registry, as of June 18, 2020, Incyte Corporation is conducting a clinical trial for Ruxolitinib in the treatment of Vitiligo which is in phase II development in the United States. This factor will boost the market if Ruxolitinib drug gets approved for the treatment of Vitiligo in the near future.

Additionally, topical corticosteroids (TC) application to treat pigmentation disorders is one of the most successful treatment options. Some of the commonly used corticosteroids are fluticasone propionate, betamethasone valerate, and hydrocortisone butyrate, among others.

According to the February 2021 research article published in the Journal of Investigative Dermatology titled “Efficacy and Safety of Tacrolimus 0.1% for the Treatment of Facial Vitiligo”, results demonstrated that usage of twice-daily tacrolimus 0.1% ointment showed superior efficacy with 65% Therapeutic success in 42 tacrolimus-treated patients.

According to the June 2019 research article published on SCIENCE DAILY by researchers from Tufts Medical Center in Boston, results demonstrated that Topical ruxolitinib cream was extremely effective in reversing the effects of vitiligo. The development of these therapies holds the promise to increase the accessibility of an effective, non-invasive treatment option for hand tremors. Thus, all these developments currently happening in the market are expected to offer immense growth opportunities to the segment.

The graph mentioned below suggests that how aging population are increasing in several parts of the worlds. As the aging process modifies the pigmentary system, and uneven pigmentation is one of the major changes associated with aging, which may lead to increased deman of topical treatments in aging population.

North America is Expected to Dominate the Global Pigmentation Disorders Treatment Market

North America dominates the global pigmentation disorders treatment market owing to the rising pigmentation disorders. Presence of well-established healthcare infrastructure and major market players providing effective treatment options to the patients suffering from post-inflammatory hyperpigmentation in North America. As per the National Organization for Albinism and Hypopigmentation 2018, in the United States, about one in 18,000 to 20,000 people had some type of albinism. In other parts of the world, the occurrence can be as high as one in 3,000.

For instance, according to the National Clinical Trials (NCT) Registry, as of June 21st, 2021, in the United States, there were 19 vitiligo related trials under development (with the status ”Active, not recruiting”, ”Enrolling by invitation” and ”Recruiting”, which is expected to show a positive impact on the market studied. Since vitiligo is a very common skin pigmentation disorder, increasing trials is expected to provide more treatment options, thus aiding demand.

Key Topics Covered:

1 INTRODUCTION

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

4.1 Market Overview

4.2 Market Drivers

4.2.1 Increasing Prevalence and of Pigmentation Disorders

4.2.2 Growing Expenditure on the Dermatalogical Treatments

4.3 Market Restraints

4.3.1 High Cost of the Cosmetic procedures

4.3.2 Inadequate Reimbursement Policies

4.4 Porter’s Five Force Analysis

5 MARKET SEGMENTATION

5.1 By Type of Disorder

5.2 Treatment Type

5.3 Geography

6 COMPETITIVE LANDSCAPE

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

For more information about this report visit https://www.researchandmarkets.com/r/rza6zz

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]
For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900